#	Aladdin ID	Assay Type	Description	Organism	Compounds	Reference	BAO Format	Source
1.	ALA955623	F	Antiviral activity against HBV genotype D in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
2.	ALA955624	F	Antiviral activity against HBV genotype D with reverse transcriptase L80I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
3.	ALA955625	F	Antiviral activity against HBV genotype D with reverse transcriptase M204I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
4.	ALA955626	F	Antiviral activity against HBV genotype D with reverse transcriptase L80I/M204I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
5.	ALA955627	F	Antiviral activity against HBV genotype D with reverse transcriptase L180M/M204I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
6.	ALA955628	F	Antiviral activity against HBV genotype D with reverse transcriptase L80I/L180M/M204I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
7.	ALA958071	F	Antiviral activity against HBeAg-deficient HBV genotype D with precore G1896A mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
8.	ALA958072	F	Antiviral activity against HBeAg-deficient HBV genotype D with precore G1896A mutation and reverse transcriptase L80I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
9.	ALA958073	F	Antiviral activity against HBeAg-deficient HBV genotype D with precore G1896A mutation and reverse transcriptase M204I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
10.	ALA958074	F	Antiviral activity against HBeAg-deficient HBV genotype D with precore G1896A mutation and reverse transcriptase L80I/M204I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
11.	ALA958075	F	Antiviral activity against HBeAg-deficient HBV genotype D with precore G1896A mutation and reverse transcriptase L180M/M204I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
12.	ALA958076	F	Antiviral activity against HBeAg-deficient HBV genotype D with precore G1896A mutation and reverse transcriptase L80I/L180M/M204I mutation in human Huh7 cells assessed as inhibition of viral replication after 5 days	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
13.	ALA958077	F	Antiviral activity against HBV genotype D in human Huh7 cells assessed as viral replication yield at 1 uM after 5 days relative to control	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
14.	ALA958078	F	Antiviral activity against HBV genotype D with reverse transcriptase L80I mutation in human Huh7 cells assessed as viral replication yield at 1 uM after 5 days relative to control	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
15.	ALA958079	F	Antiviral activity against HBV genotype D with reverse transcriptase M204I mutation in human Huh7 cells assessed as viral replication yield at 1 uM after 5 days relative to control	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
16.	ALA958080	F	Antiviral activity against HBV genotype D with reverse transcriptase L80I/M204I mutation in human Huh7 cells assessed as viral replication yield at 1 uM after 5 days relative to control	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
17.	ALA958882	F	Antiviral activity against HBV genotype D with reverse transcriptase L180M/M204I mutation in human Huh7 cells assessed as viral replication yield at 1 uM after 5 days relative to control	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
18.	ALA958883	F	Antiviral activity against HBV genotype D with reverse transcriptase L80I/L180M/M204I mutation in human Huh7 cells assessed as viral replication yield at 1 uM after 5 days relative to control	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
19.	ALA958884	F	Antiviral activity against HBeAg-deficient HBV genotype D with precore G1896A mutation in human Huh7 cells assessed as viral replication yield at 1 uM after 5 days relative to control	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature
20.	ALA958885	F	Antiviral activity against HBeAg-deficient HBV genotype D with precore G1896A mutation and reverse transcriptase L80I mutation in human Huh7 cells assessed as viral replication yield at 1 uM after 5 days relative to control	hepatitis B virus genotype D	1	ALA1150787	organism-based format	Scientific Literature